Details for New Drug Application (NDA): 214222
✉ Email this page to a colleague
The generic ingredient in THIOTEPA is thiotepa. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the thiotepa profile page.
Summary for 214222
Tradename: | THIOTEPA |
Applicant: | Gland Pharma Ltd |
Ingredient: | thiotepa |
Patents: | 0 |
Pharmacology for NDA: 214222
Mechanism of Action | Alkylating Activity |
Medical Subject Heading (MeSH) Categories for 214222
Suppliers and Packaging for NDA: 214222
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
THIOTEPA | thiotepa | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 214222 | ANDA | Dr.Reddy's Laboratories Inc., | 43598-171 | 43598-171-11 | 1 VIAL in 1 CARTON (43598-171-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
THIOTEPA | thiotepa | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | 214222 | ANDA | Fresenius Kabi USA, LLC | 65219-029 | 65219-029-20 | 1 VIAL in 1 CARTON (65219-029-20) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Strength | 15MG/VIAL | ||||
Approval Date: | Mar 8, 2021 | TE: | AP | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL | Strength | 100MG/VIAL | ||||
Approval Date: | Jan 3, 2022 | TE: | AP | RLD: | No |
Complete Access Available with Subscription